Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 954 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Nippon to adopt Accelrys ELN

The multidisciplinary Symyx Notebook helps in moving therapeutic substances and related information from research through development to early manufacturing using efficient, validated and compliant processes. The notebook which

Anacor concludes patient enrollment for Tavaborole trial

The Phase 3 trial includes two double-blind vehicle-controlled trials with two-to-one randomisation between Tavaborole and vehicle (the topical formulation without the active ingredient). Anacor Pharmaceuticals CEO David Perry